Found: 25
Select item for more details and to access through your institution.
A Real‐World Study on Adverse Reactions of Belimumab Based on the FDA Adverse Event Reporting System Database.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 10, p. 1, doi. 10.1002/pds.70037
- By:
- Publication type:
- Article
The Awareness of and Adherence to the Pregnancy Prevention Program for Oral Retinoids: A Questionnaire Survey in Denmark.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 10, p. 1, doi. 10.1002/pds.70023
- By:
- Publication type:
- Article
Use of Hydrochlorothiazide in the United States Following Label Update About Skin Cancer Risk.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 10, p. 1, doi. 10.1002/pds.70040
- By:
- Publication type:
- Article
Time Series Methods to Assess the Impact of Regulatory Action: A Study of UK Primary Care and Hospital Data on the Use of Fluoroquinolones.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 10, p. 1, doi. 10.1002/pds.70022
- By:
- Publication type:
- Article
Association Between Oral Fluoroquinolones and Neuropsychiatric Events: Self‐Controlled Case Series With Active Comparator Design.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 10, p. 1, doi. 10.1002/pds.70036
- By:
- Publication type:
- Article
Real‐World Assessment of Psychotropic and Antiepileptic Drug Use During Pregnancy in Belgium: Trends, Predictors, and Comparative Risk of Congenital Anomalies (2010–2016).
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 10, p. 1, doi. 10.1002/pds.70021
- By:
- Publication type:
- Article
Agreement of Medication Information Derived From EHR Data Compared to Medicare Insurance Claims: An Analysis of Biologic Disease‐Modifying Antirheumatic Drugs.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 10, p. 1, doi. 10.1002/pds.70020
- By:
- Publication type:
- Article
The Prevalent New‐User Design to Study Drug–Drug Interactions: The Example of Sulfonylureas and Warfarin Interaction on the Risk of Severe Hypoglycemia.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 10, p. 1, doi. 10.1002/pds.70014
- By:
- Publication type:
- Article
Keep Your Guard Up: The Potential Impact of Drug Shortages on Pharmacoepidemiological Studies.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 10, p. 1, doi. 10.1002/pds.70035
- By:
- Publication type:
- Article
The Use of Japanese Traditional (Kampo) Medicines Before and During Pregnancy in Japan: The Tohoku Medical Megabank Project Birth and Three‐Generation Cohort Study.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 10, p. 1, doi. 10.1002/pds.70033
- By:
- Publication type:
- Article
Mental Health and Medicine Use for Headache: A Nationally Representative Study of Adolescents in Denmark.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 10, p. 1, doi. 10.1002/pds.70031
- By:
- Publication type:
- Article
Adverse Event Assessment of Upadacitinib: A Pharmacovigilance Study Based on the FAERS Database.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 10, p. 1, doi. 10.1002/pds.70030
- By:
- Publication type:
- Article
The Impact of Hormone Replacement Therapy on the Risk of Heart Failure in Postmenopausal Women: A Meta‐Analysis of Clinical and Observational Studies.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 10, p. 1, doi. 10.1002/pds.70029
- By:
- Publication type:
- Article
The FDA Sentinel Real World Evidence Data Enterprise (RWE‐DE).
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 10, p. 1, doi. 10.1002/pds.70028
- By:
- Publication type:
- Article
Core Concepts in Pharmacoepidemiology: Quantitative Bias Analysis.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 10, p. 1, doi. 10.1002/pds.70026
- By:
- Publication type:
- Article
Dexamethasone Dose for COVID‐19 in a Large U.S. Hospital Network From April 2020 to May 2023.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 10, p. 1, doi. 10.1002/pds.70018
- By:
- Publication type:
- Article
Benfluorex and Valvular Heart Disease.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 10, p. 1, doi. 10.1002/pds.70017
- By:
- Publication type:
- Article
Drifting Too Far From Shore: Paternal Valproate Statement by the European Medicines Agency (EMA).
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 10, p. 1, doi. 10.1002/pds.70016
- By:
- Publication type:
- Article
Monitoring Pregnancies Exposed to Galcanezumab for Migraine in a United States Administrative Claims Database.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 10, p. 1, doi. 10.1002/pds.70015
- By:
- Publication type:
- Article
Validation Assessment of Privacy‐Preserving Synthetic Electronic Health Record Data: Comparison of Original Versus Synthetic Data on Real‐World COVID‐19 Vaccine Effectiveness.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 10, p. 1, doi. 10.1002/pds.70019
- By:
- Publication type:
- Article
Identifying Patients With Primary Biliary Cholangitis and Cirrhosis Using Administrative Data in a National Cohort.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 10, p. 1, doi. 10.1002/pds.70013
- By:
- Publication type:
- Article
The Effects of Removing the Requirement for Prior Reimbursement Approval on Anticoagulant Use in Ireland: A Cross‐Sectional Study.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 10, p. 1, doi. 10.1002/pds.70011
- By:
- Publication type:
- Article
Use of Omalizumab for Pediatric Asthma After US Food and Drug Administration Expanded Indications.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 10, p. 1, doi. 10.1002/pds.70009
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 10, p. 1, doi. 10.1002/pds.5830
- Publication type:
- Article
Liver Injury in People With HIV on Antituberculosis and/or Antiretroviral Therapy—Assessing Causality Using the Updated Roussel Uclaf Causality Assessment Method.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 10, p. 1, doi. 10.1002/pds.5883
- By:
- Publication type:
- Article